Clinical trial
Incidence and Mortality of Hepatocellular Carcinoma in HIV-infected Individuals in an Asian Population
NCT03702998 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence and Mortality of Hepatocellular Carcinoma in HIV-infected Individuals in an Asian Population
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2018
- Completion date
- January 16, 2023
- Enrollment
- 3,900 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b, hepatitis c, hepatocellular carcinoma, hiv infections